powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1942616404
Colin Diffie
MD
Rheumatology
Saint Louis,
MO
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
QUALITY · MIPS · 2024
Final MIPS score
84.2
Quality
71.6
Cost
75.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.39%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
1,926
Beneficiaries
—
Total drug cost
$2.0M
Distinct drugs
39
Brand share
36.2%
Top prescribed drugs
Prednisone
327 claims
Methotrexate Sodium
273 claims
Hydroxychloroquine Sulfate
231 claims
Adalimumab
79 claims
Mycophenolate Mofetil
66 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
521
Unique beneficiaries
—
Total services
4,013
Distinct HCPCS
14
Medicare payment
$71K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 94 Rheumatology providers in MO — above median (cohort median 1,226).